Opportunity
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Response due
November 10, 2026
- Agency
- Advanced Research Projects Agency for Health (arpa-H)
- Estimated value
- Not stated
October 21, 2026 FASTPASS ISO, ARPA-H-SOL-26-160, Amendment 01 The purpose of Amendment 01 is to: (1) Revise Section 1.2 of the Appendix C.3: Cost Proposal Narrative Model; (2) Rename Attachment D: Cost Proposal Workbook to Appendix D: Cost Proposal Workbook; and (3) Revise item 4 under the General tab of Appendix D: Cost Proposal Workbook to correct a typographical error. No other changes were made to the body of the ISO or appendices. See attached FASTPASS ISO, ARPA-H-SOL-26-160, Amendment 01. _________________________ August 20, 2026 The Advanced Research Projects Agency for Health (ARPA-H) Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) program aims to develop a near real-time, non-destructive, AI-enabled system for screening pharmaceutical products and inputs through their packaging at ports of entry and other supply-chain nodes. Interested parties are invited to review the attached FASTPASS Innovative Solutions Opening, ARPA-H-SOL-26-160.
Key dates
- Posted
- October 21, 2026
- Response due
- November 10, 2026
Who is this buyer
Organization
Buying history
- Records7 total
- Opportunities / awards2 / 0
- ActiveJuly 28, 2026 – October 21, 2026
What they buy
- Clinical (5)
- Administrative (2)
Set-asides used
- Small Business Set Aside - Total (1)
Also open from this buyer
- Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions OpeningDue November 10, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 541715
- PSC
- AN13